Lesley C. Lomo
No Rating Available
(Learn About Our Rating System)

Lesley C. Lomo, MD, MS

Languages spoken: English

Surgical Pathologist and Cytopathologist with subspecialty expertise in gynecologic and breast surgical pathology and fine needle aspiration cytopathology. Additional interests include undergraduate and graduate medical education in pathology.

Specialties

  • Breast Pathology
  • Pathology, Anatomical
  • Cytopathology
  • Gynecologic Pathology

Board Certification

American Board of Pathology (Sub: Cytopathology)
American Board of Pathology (Anatomic & Clinical)

Surgical Pathologist and Cytopathologist with subspecialty expertise in gynecologic and breast surgical pathology and fine needle aspiration cytopathology. Additional interests include undergraduate and graduate medical education in pathology.

Board Certification and Academic Information

Academic Departments Pathology -Professor (Clinical)
Board Certification
American Board of Pathology (Sub: Cytopathology)
American Board of Pathology (Anatomic & Clinical)

Education history

Undergraduate English - University of Michigan B.A.
Graduate Training Basic Medical Sciences - Wayne State University School of Medicine M.S.
Professional Medical Medicine - Wayne State University School of Medicine M.D.
Residency Anatomic and Clinical Pathology - Brigham and Women¿s Hospital Resident
Fellowship Gynecologic Pathology - Brigham and Women¿s Hospital Fellow
Fellowship Breast Pathology - Brigham and Women¿s Hospital Fellow
Chief Resident Anatomic Pathology - Brigham and Women¿s Hospital Chief Resident
Fellowship Cytopathology - Brigham and Women¿s Hospital Fellow

Selected Publications

Journal Article

  1. Garg D, Johnstone EB, Lomo L, Fair DB, Rosen MP, Taylor R, Silver B, Letourneau J (2020). Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. Journal of assisted reproduction and genetics, 37(6), 1467-1476.
  2. Blair CK, Wiggins CL, Nibbe AM, Storlie CB, Prossnitz ER, Royce M, Lomo LC, Hill D (2019). Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics. NPJ breast cancer, 5, 33.
  3. Brocato TA, Brown-Glaberman U, Wang Z, Selwyn RG, Wilson CM, Wyckoff EF, Lomo LC, Saline JL, Hooda-Nehra A, Pasqualini R, Arap W, Brinker CJ, Cristini (2019). Predicting breast cancer response to neoadjuvant chemotherapy based on tumor vascular features in needle biopsies. JCI insight, 5,
  4. Harris CK, Chen Y, Alston EL, Brown A, Chabot-Richards D, Dintzis SM, Graber ML, Jackups R Jr, Lomo LC, Laudadio J, Markwood PS, Nielson KJ, Samedi V, Sampson B, Haspel RL, Zafar N, Montone KT, Childs J, White KL, Heher Y (2023). The next phase in patient safety education: Towards a standardized, tools-based pathology patient safety curriculum: A call to action from the Association of Pathology Chairs' Residency Program Directors Section Training Residents in Patient Safety Workgroup. Academic pathology, 10(2), 100081.
  5. Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Burlingame J, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim JT, Coleman JF, Deftereos G, Gulbahce EH, Sirohi (2023). Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer. Archives of pathology & laboratory medicine,
  6. McMurtry V, Mahlow J, Coleman JF, Deftereos G, Jattani R, Bastien RRL, Durtschi J, Jarboe E, Lomo L, Sirohi (2023). Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle Tumors. American journal of clinical pathology, 159(2), 164-171.
  7. Garg D, Hodgman M, Reil S, Lomo L, Aston KI, Hill J, Johnstone E, Jenkins T, Letourneau J (2022). Effect of chemotherapy on the uterus of young adult cancer survivors. F&S reports, 3(3), 198-203.
  8. McMurtry V, Cleary AS, Ruano AL, Lomo L, Gulbahce H (2023). Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database. American journal of clinical oncology, 46(12), 559-566.
  9. Balatico M, Ruano AL, Cleary AS, Lomo L, Gulbahce H (2024). Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database. Archives of pathology & laboratory medicine, 148(3), 263-264.
  10. Schmidt RL, White SK, Timme KH, McFarland MM, Lomo L (2024). Graduate Medical Education in Pathology: A Scoping Review. Archives of pathology & laboratory medicine, 148(1), 117-127.
  11. Beech C, Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim J, Coleman JF, Deftereos G, Gulbahce EH, Sirohi (2025). Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization. Applied immunohistochemistry & molecular morphology, 33(2), 91-102.
  12. Brunyé TT, Shucard H, Eguchi MM, Drew T, Marotti J, Lomo LC, Kilgore MR, Allison KH, Kerr KF, Elmore JG, Weaver D (2025). Characterizing Interpretive and Diagnostic Competency Development in Pathology Training. Modern pathology, 100802.

Review

  1. Sama S, Rosqvist S, Savage T, Lomo L, Sibbald K, Straubhar A, Werner T (2024). Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer. Gynecologic oncology reports, 53, 101412.
  2. Potter S, Gulbahce E, Porretta J, Lomo L, Duffy K, Winkler N, Coleman J, Jedrzkiewicz (2025). Invasive Squamous Cell Carcinoma of the Nipple: Case Report With Literature Review. The American Journal of dermatopathology, 47(3), 220-223.